News & Updates
Excerpt from the article: Innovative Solutions Canada has dedicated funding to help combat current and future outbreaks of the novel coronavirus (COVID-19) and other similar threats. Our program will help support the Government of Canada’s fight against COVID-19 by funding R&D and testing prototypes in real-life settings that can help protect Canadians. Click the button…
Read More
Excerpt from the article: When the spread of COVID-19 started to affect the University of Connecticut, the state, and the country, Ranjan Srivastava, department head for Chemical and Biomolecular Engineering, knew he had to spring into action. Drawing on his previous work in mathematically modeling how the Hepatitis B virus spreads, Srivastava realized he could…
Read More
Excerpt from the article: PITTSBURGH, April 9, 2020 – A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched today at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies, such as the anti-malarial drug hydroxychloroquine,…
Read More
Excerpt from the article: “DURHAM — Front-line health-care workers dealing with the COVID-19 pandemic are getting a helping hand from Ontario Power Generation and Ontario Tech University in Oshawa. OPG is using 3D printing technology to produce plastic face shields and the company has partnered with Ontario Tech University to fast-track the production of this…
Read More
Excerpt from the article: “RICHMOND, Va. (WRIC) — VCU Health is in the middle of conducting clinical trials for an experimental drug that could possibly treat COVID-19. Dr. Arun Sanyal, the doctor leading the trials, told 8News Tuesday that results are encouraging and it’s about improving how a patient feels, functions and survives. Remdesivir, a…
Read More
Excerpt from the Article: “Hemarina, a French biotech company, could come to the help of doctors fighting the coronavirus. The company has developed a molecule derived from marine worms, which could help people seriously affected by the COVID-19, who do not have access to respirators. The molecule called M101, binds 40 times more oxygen than…
Read More
Excerpt from the article: “PORTLAND, Ore. — Providence researchers in Portland submitted a request to the Food and Drug Administration for the first clinical trial of a viral COVID-19 vaccine. The Earl A. Chiles Research Institute (EACRI) at Providence’s Robert W. Franz Cancer Center is using its knowledge of cancer vaccine immunotherapy to develop a…
Read More
Excerpt from the article: “A team of blood transfusion experts from across Canada is planning the world’s largest clinical trial of a potential treatment for COVID-19. The study, which will involve 1,000 patients from across the country, will include at least 40 Canadian hospitals, and is being overseen by doctors from the University of Montreal,…
Read More
Excerpt from the article: “The Food and Drug Administration is expected to approve the first of a whole new type of weapon to be tested in the international struggle against COVID-19 as the disease continues to sweep across the globe. New Jersey-based therapeutics company Celularity announced that its cancer treatment, CYNK-001, is awaiting “investigational new…
Read More
Meaghan Powers, lead consultant, Halloran Consulting Group penned an excellent article on integrating Quality Management with RBM Meaghan tackles a number topics in the 3 Key Steps To Successful Execution. First, a risk assessment must be conducted both pre-study and ongoing during the trial. Second, a well-articulated study protocol should be developed based on factors…
Read MoreRequest Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?